| 产品名称 |
点击数 |
| Anti-Human VIM/Vimentin Recombinant Antibody , PE|抗人VIM/波形蛋白重组抗体,PE标记(靶标:波形蛋白) |
460 |
| Anti-Human KRT19/CK19 Recombinant Antibody , PE|抗人KRT19/CK19重组抗体,PE标记(靶标:角蛋白19/细胞角蛋白19) |
327 |
| Anti-Human CD126/IL6R/IL-6RA Recombinant Antibody , PE|抗人CD126/IL6R/IL-6RA重组抗体,PE标记(靶标:白细胞介素6受体/CD126) |
354 |
| Anti-Human CD126/IL6R/IL-6RA Recombinant Antibody , PE|抗人CD126/IL6R/IL-6RA重组抗体,PE标记(靶标:白细胞介素6受体/CD126) |
334 |
| Anti-Human CD63/LAMP3 Recombinant Antibody, PE|抗人CD63/LAMP3重组抗体,PE标记(靶标:溶酶体相关膜蛋白3/CD63) |
363 |
| Anti-Human CD63/LAMP3 Recombinant Antibody , PE|抗人CD63/LAMP3重组抗体,PE标记(靶标:溶酶体相关膜蛋白3/CD63) |
458 |
| Anti-Human FGF2/bFGF Recombinant Antibody , PE|抗人FGF2/bFGF重组抗体,PE标记(靶标:成纤维细胞生长因子2/碱性成纤维细胞生长因子) |
474 |
| Anti-Human CD48 Recombinant Antibody , PE|抗人CD48重组抗体,PE标记(靶标:CD48分子) |
187 |
| Anti-Human CD48 Recombinant Antibody, PE|抗人CD48重组抗体,PE标记(靶标:CD48分子) |
510 |
| Anti-Human CXCL1/NAP-3/GRO-alpha Recombinant Antibody , PE|抗人CXCL1/NAP-3/GRO-α重组抗体,PE标记(靶标:CXC趋化因子配体1/中性粒细胞活化肽-3/生长调节癌基因α) |
225 |
| Anti-Human CD7 Recombinant Antibody, PE|抗人CD7重组抗体,PE标记(靶标:CD7分子) |
243 |
| Anti-Human CD7 Recombinant Antibody, PE|抗人CD7重组抗体,PE标记(靶标:CD7分子) |
216 |
| Anti-Human CSF1/M-CSF Recombinant Antibody , PE|抗人CSF1/M-CSF重组抗体,PE标记(靶标:集落刺激因子1/巨噬细胞集落刺激因子) |
292 |
| Anti-Human CD140b/PDGFRB Recombinant Antibody , PE|抗人CD140b/PDGFRB重组抗体,PE标记(靶标:血小板衍生生长因子受体β/CD140b) |
228 |
| Anti-Human CD140b/PDGFRB Recombinant Antibody, PE|抗人CD140b/PDGFRB重组抗体,PE标记(靶标:血小板衍生生长因子受体β/CD140b) |
481 |
| Anti-Human TACSTD2/TROP2 Recombinant Antibody , PE|抗人TACSTD2/TROP2重组抗体,PE标记(靶标:肿瘤相关钙信号转导蛋白2/TROP2) |
435 |
| Anti-Human TACSTD2/TROP2 Recombinant Antibody, PE|抗人TACSTD2/TROP2重组抗体,PE标记(靶标:肿瘤相关钙信号转导蛋白2/TROP2) |
385 |
| Anti-Human C1S Recombinant Antibody , PE|抗人C1S重组抗体,PE标记(靶标:补体C1s亚基) |
516 |
| Anti-Human CSF3/G-CSF Recombinant Antibody , PE|抗人CSF3/G-CSF重组抗体,PE标记(靶标:集落刺激因子3/粒细胞集落刺激因子) |
491 |
| Anti-Human GZMB Recombinant Antibody, PE|抗人GZMB重组抗体,PE标记(靶标:颗粒酶B) |
325 |